Trial intelligence / Profile preview

Ultrasound-Guided SGB with Botox vs Steroid in Refractory Bell's Palsy

NCT05099835Completed

Sponsor
Assiut University
Start
Nov 2021
Primary completion
Jun 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of botulinum toxin type A in Bell's palsy (2 arms), sponsored by Assiut University. Primary endpoint: Change from Baseline House-Brackmann Score at 3 months. Started Nov 2021; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Bell's palsy

Beyond the preview

Go deeper on NCT05099835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05099835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call